Skip to main content

Fate Therapeutics, Inc. (NASDAQ: FATE) Investor Investigation Over Potential Wrongdoing Announced

  • Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) and currently hold any of those NASDAQ: FATE shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) was announced over potential breaches of fiduciary duties by certain officers and directors at Fate Therapeutics, Inc. The investigation by a law firm concerns whether certain Fate Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its share...



You must register (for free) or login to view the entire investigation.